Literature DB >> 25932450

A case of pentasomy 21 with two isochromosome 21s in acute megakaryoblastic leukemia associated with Down syndrome.

Yeongchun Park1, Jinsook Lim1, Yong Hyun Ko1, Jimyung Kim1, Gye Cheol Kwon1, Sun Hoe Koo1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25932450      PMCID： PMC4390710          DOI： 10.3343/alm.2015.35.3.373

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN： 2234-3806            Impact factor:   3.464


× No keyword cloud information.
  9 in total

1.  Chromosome 19 abnormalities are commonly seen in AML, M7.

Authors:  Stephen D Nimer; Donal MacGrogan; Suresh Jhanwar; Sara Alvarez
Journal:  Blood       Date:  2002-11-15       Impact factor: 22.113

2.  Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle.

Authors:  Hazel M Robinson; Christine J Harrison; Anthony V Moorman; Ilse Chudoba; Jonathan C Strefford
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

Review 3.  The role of chromosome 21 in hematology and oncology.

Authors:  Christa Fonatsch
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

Review 4.  Tetrasomy 21 as a sole chromosome abnormality in acute myeloid leukemia. fluorescence in situ hybridization and spectral karyotyping analyses.

Authors:  Akimichi Ohsaka; Tomoko Hisa; Norimichi Watanabe; Hiroshi Kojima; Toshiro Nagasawa
Journal:  Cancer Genet Cytogenet       Date:  2002-04-01

5.  Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization.

Authors:  S Alvarez; D MacGrogan; M J Calasanz; S D Nimer; S C Jhanwar
Journal:  Genes Chromosomes Cancer       Date:  2001-11       Impact factor: 5.006

6.  Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.

Authors:  E Hilgenfeld; H Padilla-Nash; N McNeil; T Knutsen; C Montagna; J Tchinda; J Horst; W D Ludwig; H Serve; T Büchner; W E Berdel; E Schröck; T Ried
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

Review 7.  Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.

Authors:  Anindita Roy; Irene Roberts; Alice Norton; Paresh Vyas
Journal:  Br J Haematol       Date:  2009-07-06       Impact factor: 6.998

8.  Duplication of isodicentric chromosome 21, idic(21)(p11.2), leading to pentasomy 21q in acute myeloid leukemia with multilineage dysplasia.

Authors:  Manabu Shimoyama; Katsuya Yamamoto; Shinichiro Nishikawa; Kentaro Minagawa; Yoshio Katayama; Toshimitsu Matsui
Journal:  Cancer Genet Cytogenet       Date:  2009-10

9.  Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.

Authors:  J E Cortes; H Kantarjian; S O'Brien; M Keating; S Pierce; E J Freireich; E Estey
Journal:  Leukemia       Date:  1995-01       Impact factor: 11.528
  9 in total
  1 in total

1.  Mosaic complete tetrasomy 21 in a fetus with complete atrioventricular septal defect and minor morphological variations.

Authors:  Vincent Gatinois; Nicole Bigi; Eve Mousty; Jean Chiesa; Yuri Musizzano; Anouck Schneider; Geneviève Lefort; Lucile Pinson; Jean-Baptiste Gaillard; Clémence Ragon; Marie-Josée Perez; Magali Tournaire; Patricia Blanchet; Carole Corsini; Emmanuelle Haquet; Patrick Callier; David Geneviève; Franck Pellestor; Jacques Puechberty
Journal:  Mol Genet Genomic Med       Date:  2019-09-07       Impact factor: 2.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.